JNJ Johnson & Johnson Earnings and EPS analysis

EPS in 2026 (TTM): $8.73

Last Report Period Date: Jun 28, 2026

As of August this year, based on Johnson & Johnson's most recent financial report, the company's trailing twelve months EPS is $8.73. Johnson & Johnson's earnings per share in 2025 was reported at $11.13, marking a rise from $5.84 in 2024. Johnson & Johnson's EPS for the quarterly period ending on Jun 28, 2026 came in at $2.3.

The yearly earnings per share during 2025 was $11.13, a rise of 90.6% compared to $5.84 recorded in 2024. Over the quarter ending Jun 28, 2026, the earnings per share came in at $2.3, reflecting no change compared to the same quarter last year. The trailing twelve months EPS for JNJ is $8.73 as of June 2026. Johnson & Johnson's full-year EPS for 2024 was $5.84, a 57.9% decline compared to the previous year.

Johnson & Johnson has recorded no change in earnings per share over the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 17.7% per year. In the last five years, the company had an average annual EPS growth of 14.8%. When assessed over a ten-year period, JNJ's average EPS annual growth was 7.2%.